Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 09, 2026 1.045
October 08, 2026 1.039
October 07, 2026 1.041
October 06, 2026 1.052
October 05, 2026 1.056
October 02, 2026 1.084
October 01, 2026 1.076
September 30, 2026 1.101
September 29, 2026 1.099
September 28, 2026 1.084
September 25, 2026 1.078
September 24, 2026 1.086
September 23, 2026 1.088
September 22, 2026 1.111
September 21, 2026 1.074
September 18, 2026 1.025
September 17, 2026 1.011
September 16, 2026 0.9878
September 15, 2026 0.9761
September 14, 2026 0.9859
September 11, 2026 1.021
September 10, 2026 1.043
September 09, 2026 1.076
September 08, 2026 1.127
September 04, 2026 1.215
Date Value
September 03, 2026 1.217
September 02, 2026 1.215
September 01, 2026 1.191
August 31, 2026 1.146
August 28, 2026 1.352
August 27, 2026 1.383
August 26, 2026 1.469
August 25, 2026 1.461
August 24, 2026 1.356
August 21, 2026 1.305
August 20, 2026 1.260
August 19, 2026 1.348
August 18, 2026 1.322
August 17, 2026 1.286
August 14, 2026 1.348
August 13, 2026 1.324
August 12, 2026 1.369
August 11, 2026 1.424
August 10, 2026 1.496
August 07, 2026 1.094
August 06, 2026 1.078
August 05, 2026 0.9272
August 04, 2026 0.9291
August 03, 2026 0.8998
July 31, 2026 0.8274

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 19.19
Anika Therapeutics, Inc. 1.909
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.203

Price to Book Value Related Metrics

PS Ratio 1.762
Price 5.34
Earnings Yield -137.0%
Market Cap 33.30M